BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16105523)

  • 1. Is transarterial chemoembolization necessary before liver transplantation for hepatocellular carcinoma?
    Pérez Saborido B; Meneu JC; Moreno E; García I; Moreno A; Fundora Y
    Am J Surg; 2005 Sep; 190(3):383-7. PubMed ID: 16105523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M
    Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
    Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
    Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
    Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
    Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of treatment of hepatocellular carcinoma before liver transplantation on post transplant tumor recurrence and survival].
    Díaz-Sánchez A; Matilla A; Núñez O; Merino B; Peligros I; Rincón D; Salcedo M; Lo Iacono O; Vega Catalina M; Clemente G; Bañares R
    Gastroenterol Hepatol; 2010 Mar; 33(3):155-64. PubMed ID: 19945770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma.
    Millonig G; Graziadei IW; Freund MC; Jaschke W; Stadlmann S; Ladurner R; Margreiter R; Vogel W
    Liver Transpl; 2007 Feb; 13(2):272-9. PubMed ID: 17256758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.
    Schaudt A; Kriener S; Schwarz W; Wullstein C; Zangos S; Vogl T; Mehrabi A; Fonouni H; Bechstein WO; Golling M
    Clin Transplant; 2009 Dec; 23 Suppl 21():61-7. PubMed ID: 19930318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
    Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
    Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
    Kaibori M; Tanigawa N; Matsui Y; Saito T; Uchida Y; Ishizaki M; Tanaka H; Kamiyama Y
    Anticancer Res; 2006; 26(5B):3685-92. PubMed ID: 17094386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and prognostic value of proliferating cell nuclear antigen in hepatocellular carcinoma patients received preoperative transcatheter arterial chemoembolization].
    Guo RP; Yu WS; Wei W
    Ai Zheng; 2008 Feb; 27(2):201-5. PubMed ID: 18279622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A comparison of patients with hepatocellular carcinoma between a short-term (less than 6 months) survival group and a long-term (over 24 months) survival group after treatment with transcatheter arterial chemoembolization].
    Kang IK; Kim SW; Hahn SH; Cho SC; Gham CW; Lee DH
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):189-200. PubMed ID: 12499805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J; Wu Z; Tang Z
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
    Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
    Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma].
    Zhang Z; Wu M; Liu Q
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):214-6. PubMed ID: 11776840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma].
    Wang QX; Yan JJ; Zhou FG; Shen J; Yan YQ
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):748-51. PubMed ID: 19615209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ; An SY; Moon EJ; Lee MS; Hwang JA; Cheong JY; Won JH; Kim JK; Wang HJ; Cho SW
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.